The CEVHAP logo was developed to establish a visual identity that represents the ethos
and purpose of the organisation:

Circle elements
signifies cooperation, coalition of
individuals working on a unified goal.

Virus symbols
the five major causes of viral hepatitis,
(A-E) are encapsulated in abstract in
this stylization of the virus: the three
that cause chronic infection B, C & D
are enveloped, whilst the two that
cause acute, self-limiting hepatitis, A &
E, are exposed.

Globe concept
represents the Asia Pacific region,
which occupies roughly, more than half
the globe. The tilt emulates the
earth's tilted axis, while maintaining
visual balance.

Bowl element
suggests containment, protection and
safekeeping, while visually reinforcing
transparency. It also indicates
movement and fluidity in development
of structures and policies.

the font has a modern feel, yet
displays a subtle connection to
traditional calligraphy and hand
written text of many Asian cultures,
giving it a personal identity signifying
dedication and care.


warm and friendly, symbolizes the
sun, positive energy, generosity and

cool colour referring to water and air,
with a strong association with healing,
health, longevity and harmony.

FaLang translation system by Faboba


>> CEVHAP Strategy 2017-2021



NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video:

Viral Hepatitis
  Globally, 2 billion people have been
infected with hepatitis B virus, with an
estimated 600,000 dying each year . . .
  The number of people with chronic
hepatitis C and more advanced liver
disease or cirrhosis, is projected to
increase by 38% between 2006 and 2015
unless the number of people being
treated increases substantially.
  There is no vaccine for hepatitis C but
approximately 80% of patients who are
able to complete recommended
treatment, are cured . . .
Why hepatitis policy matters - the story of Baltazar Lucas  
Video What are the dangers of viral #hepatitis? Hear what #CEVHAP Chair Prof Ding-Shinn Chen had to say to the Wall Street Journal.
A Message from DS Chen
Chairman, CEVHAP


Connect with usconnect with CEVHAP